Publications by authors named "Karen Bush"

Claim this Profile
S
SAND: a comprehensive annotation of class D β-lactamases using structural alignment-based numbering.
Fedaa Attana, Soobin Kim, James Spencer, Bogdan I Iorga, Jean-Denis Docquier, Karen Bush

Antimicrob Agents Chemother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Past, present, and future perspectives on aztreonam and avibactam.
Karen Bush

Expert Rev Anti Infect Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification for β-lactamases: historical perspectives.
Karen Bush

Expert Rev Anti Infect Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Tribute to George A. Jacoby.
Karen Bush, David C Hooper, Robert A Bonomo, Patricia A Bradford, George Eliopoulos

Antimicrob Agents Chemother· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates.
Qingyu Zhang, Nicholas Neidig, Ting-Yu Chu, Cameron Divoky, Jessica Carpenter, Karen Bush

Diagn Microbiol Infect Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus on β-Lactamase Nomenclature.
Patricia A Bradford, Robert A Bonomo, Karen Bush, Alessandra Carattoli, Michael Feldgarden

Antimicrob Agents Chemother· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Success and Challenges Associated with Large-Scale Collaborative Surveillance for Carbapenemase Genes in Gram-Negative Bacteria.
Sanchita Das, Karen Bush

Antimicrob Agents Chemother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical analysis of antibacterial agents in clinical development.
Ursula Theuretzbacher, Karen Bush, Stephan Harbarth, Mical Paul, John H Rex

Nat Rev Microbiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of β-Lactamase-Producing Pathogens.
Karen Bush, Patricia A Bradford

Clin Microbiol Rev· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Standard Numbering Scheme for Class C β-Lactamases.
Andrew R Mack, Melissa D Barnes, Magdalena A Taracila, Andrea M Hujer, Kristine M Hujer, Karen Bush

Antimicrob Agents Chemother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of imipenem/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance.
Jessica Carpenter, Nick Neidig, Alex Campbell, Tanner Thornsberry, Taylor Truex, Karen Bush

J Antimicrob Chemother· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Interplay between β-lactamases and new β-lactamase inhibitors.
Karen Bush, Patricia A Bradford

Nat Rev Microbiol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Interplay between β-lactamases and new β-lactamase inhibitors.
Karen Bush, Patricia A Bradford

Nat Rev Microbiol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay between β-lactamases and new β-lactamase inhibitors.
Karen Bush, Patricia A Bradford

Nat Rev Microbiol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Meandering Path from Biochemist to Microbiologist.
Karen Bush

ACS Infect Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Past and Present Perspectives on β-Lactamases.
Karen Bush

Antimicrob Agents Chemother· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
Peera Hemarajata, Thomas Amick, Shangxin Yang, Aric Gregson, Cameron Holzmeyer, Karen Bush

J Antimicrob Chemother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Game Changers: New β-Lactamase Inhibitor Combinations Targeting Antibiotic Resistance in Gram-Negative Bacteria.
Karen Bush

ACS Infect Dis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual carbapenem resistant but ceftriaxone and cefepime susceptible isolated from a blood culture: Case report and whole-genome sequencing investigation.
Shangxin Yang, Peera Hemarajata, Laura Shevy, Mario Maciariello, Karissa Culbreath, Karen Bush

IDCases· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Yunliang Zhang, Ankita Kashikar, Karen Bush

J Antimicrob Chemother· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual Escherichia coli PBP 3 Insertion Sequence Identified from a Collection of Carbapenem-Resistant Enterobacteriaceae Tested with a Combination of Ceftazidime-, Ceftaroline-, or Aztreonam-Avibactam.
Yunliang Zhang, Ankita Kashikar, C Adam Brown, Gerald Denys, Karen Bush

Antimicrob Agents Chemother· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Furlan et al., "Importance of Sequencing To Determine Functional Variants".
George A Jacoby, Karen Bush

Antimicrob Agents Chemother· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.
Karen Bush, Malcolm G P Page

J Pharmacokinet Pharmacodyn· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Curious Case of TEM-116.
George A Jacoby, Karen Bush

Antimicrob Agents Chemother· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cathelicidin Antimicrobial Peptides with Reduced Activation of Toll-Like Receptor Signaling Have Potent Bactericidal Activity against Colistin-Resistant Bacteria.
Cheng Kao, Xiaoyan Lin, Guanghui Yi, Yunliang Zhang, Dean A Rowe-Magnus, Karen Bush

mBio· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis